The stimulatory effect of mu- and delta-opioid receptors on bovine pinealocyte melatonin synthesis

Journal of Pineal Research

Volumn 37, Issue 4, 2004, Pages 223-229

  Chuchuen, Uayart ^a   Ebadi, Manuchair ^b   Govitrapong, Piyarat ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Cyclic AMP; Melatonin; Naloxone; Opioid receptor; Pineal; Serotonin N acetyltransferase

Indexed keywords

ACYLTRANSFERASE; ADENYLATE CYCLASE; CYCLIC AMP; DELTA OPIATE RECEPTOR; ENKEPHALIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MELATONIN; MORPHINE; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE;

ANIMAL CELL; ARTICLE; CATTLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; HORMONE RELEASE; HORMONE SYNTHESIS; NONHUMAN; PINEALOCYTE; PROTEIN DETERMINATION; REGULATORY MECHANISM;

ACETYLTRANSFERASES; ANALGESICS, OPIOID; ANIMALS; CATTLE; CELLS, CULTURED; CYCLIC AMP; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; FEMALE; MELATONIN; NALOXONE; NARCOTIC ANTAGONISTS; PINEAL GLAND; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 7644225280     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2004.00155.x     Document Type: Article

References (39)

1. KAPPERS JA. The pineal organ: an introduction. In: The Pineal Gland. Wolstenholme GEW, Knight J eds. Churchile, London, 1971, pp. 3-34
2. TRICOIRE H, LOCATELLI A, CHEMINEAU P et al. Melatonin enters the cerebrospinal fluid through the pineal recess. Endocrinology 2002;143: 84-90.
3. EBADI M, GOVITRAPONG P. Neural pathways and neurotransmitters affecting melatonin synthesis. J Neural Transm Suppl 1986;21: 125-155.
4. EBADI M, HEXUM TD, PFEIFFER RF et al. The pineal and retinal peptides and their peptides. Pineal Res Rev 1989;7: 1-156.
5. VUOLTEENAHO O, VAKKURI O, LEPPALUOTO J. Wide distribution of beta-endorphin-like immunoreactivity in extrapituitary tissues of rat. Life Sci 1980;27: 57-65.
6. SPAMPINATO S, CANDELETTI S, ROMUALDI P et al. Effects of hypothalamic lesions on the content of dynorphin immunoreactivity in pituitary. Life Sci 1983;33: 503-506.
7. UDENFRIEND S, KILPATRICK DL. Proenkephalin and products of its processing: chemistry and biology. In: Analysis, Synthesis, Biology. Udenfriend S, Meinhofer J eds. Academic Press, New York, 1984; pp. 25-68.
8. CHERDCHU C, LI W, HEXUM TD et al. [Met5]-enkephalin like immunoactivity in the bovine pineal gland. Neuroendocrinol Lett 1992;11: 69-74.
9. MØLLER M, BAERES FM. The anatomy and innervation of the mammalian pineal gland. Cell Tissue Res 2002;309: 139-150.
10. SIMONNEAUX V, RIBELAYGA C. Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol Rev 2003;55: 325-395.
11. SCHRODER H, WEIHE E, NOHR D et al. Immunohistochemical evidence for the presence of peptides derived from proenkephalin, prodynorphin and proopiomelanocortin in the guinea pig pineal gland. Histochemistry 1988;88: 333-341.
12. MOORE RY, SIBONY P. Enkephalin-like immunoreactivity in neurons in the human pineal gland. Brain Res 1988;457: 395-398.
13. MOLLER M, MIKKELSEN JD, PHANSUWAN-PUJITO P. Demonstration of nerve fibers immunoreactive to met-enkephalin and β-endorphin in the bovine pineal gland. In: Role of Melatonin and Pineal Peptides in Neuroimmunomodulation. Fraschini F, Reiter RJ eds. Plenum Press, New York, 1991, pp. 15-25.
14. COTO-MONTES A, MASSON-PEVET M, PEVET P et al. The presence of opioidergic pinealocytes in the pineal gland of the European hamster (Cricetus cricetus): an immunocytochemical study. Cell Tissue Res 1994;278: 483-491.
15. PHANSUWAN-PUJITO P, JITJAIJAMJANG W, EBADI M et al. Opioidergic innervation of the tree shrew pineal gland: an immunohistochemical study. J Pineal Res 1998;24: 209-214.
16. GEFFARD M, GAFFORI O, CHAUVEAU J et al. Dramatic increase in pineal melatonin levels in the rat after subcutaneous injection of des-tyrosinel-gamma- endorphin. Neurosci Lett 1981;27: 329-334.
17. ESPOSTI D, ESPOSTI G, LISSONI P et al. Action of morphine on melatonin release in the rat. J Pineal Res 1988;5: 35-39.
18. LEWCZUK B, PRZYBYLSKA-GORNOWICZ B, WYRZYKOWS Z. The effect of morphine on melatonin secretion in the domestic pig: in vivo and in vitro study. Neuroendocrinol Lett 1999;20: 171-178.
19. YU CX, WU GC, XU SF et al. Melatonin influences the release of endogenous opioid peptides in rat periaqueductal gray. Sheng Li Xue Bao 2000;52: 207-210.
20. GOVITRAPONG P, JITAIJAMJANG W, CHETSAWANG B et al. Existence and function of opioid receptors on mammalian pinealocytes. J Pineal Res 1998;24: 201-208.
21. GOVITRAPONG P, PARIYANONTH M, EBADI M. The presence and actions of opioid receptors in bovine pineal gland. J Pineal Res 1992;13: 124-132.
22. ALOYO VJ. Identification and characterization of delta opioid binding sites in the bovine pineal. J Pharmacol Exp Ther 1992;262: 292-297.
23. GOVITRAPONG P, SAWLOM S, CHETSAWANG B et al. The bovine pineal gland contains delta and mu but not kappa or ORL1 opioid receptor subtypes. Proc West Pharmacol Soc 2002;45: 32-35.
24. GOVITRAPONG P, SAWLOM S, EBADI M. The presence of delta and mu-, but not kappa or ORL(1) receptors in bovine pinealocytes. Brain Res 2002;951: 23-30.
25. BRADFORD MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-254.
26. SIMON EJ, HILTER JM, GROTH J et al. Further properties of stereospecific opiate binding sites in rat brain. J Pharmacol Exp Ther 1975;192: 531-537.
27. MARONDE E, WICHT H, TASKEN K et al. CREB phosphorylation and melatonin biosynthesis in the rat pineal gland: involvement of cyclic AMP dependent protein kinase type II. J Pineal Res 1999;27: 170-182.
28. KLEIN DC, GANGULY S, COON S et al. 14-3-3 Proteins and photoneuroendocrine transduction: role in controlling the daily rhythm in melatonin. Biochem Soc Trans 2002;30: 365-373.
29. GANGULY S, GASTEL JA, WELLER JL et al. Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-3-3-binding switch in melatonin synthesis. Proc Natl Acad Sci USA 2001;98: 8083-8088.
30. UHL GR, CHILDER S, PATERNAK G. An opiate receptor gene family reunion. Trends Neurosci 1994;17: 89-93.
31. CRAIN SM, SHEN KF. Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol Sci 1990;11: 77-81.
32. DEVINE DP, LEONE P, WISE RA. Mesolimbic dopamine neurotransmission is increased by administration of mu-opioid receptor antagonists. Eur J Pharmacol 1993;243: 55-64.
33. CHIRA GD, NORTH RA. Neurobiology of opiate abuse. Trends Pharmacol Sci 1992;13: 185-193.
34. NEAL MJ, PATERSON SJ, CUNNINGHAM JR. Enhancement of retinal acetylcholine release by DAMGO: possibly a direct opioid receptor-mediated excitatory effect. Br J Pharmacol 1994;113: 789-794.
35. CAHILL CM, WHITE TD, SAWYNOK J. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes. J Pharmacol Exp Ther 1995;275: 84-93.
36. YOSHIMURA M, IKEDA H, TABAKOFF B. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase. Mol Pharmacol 1996;50: 43-51.
37. NEVO I, AVIDOR-REISS T, LEVY R et al. Acute and chronic activation of the mu-opioid receptor with the endogenous ligand endomorphin differentially regulates adenylyl cyclase isozymes. Neuropharmacology 2000;39: 364-371.
38. CHETSAWANG B, CASALOTTI SO, PHANSUWAN-PUJITO P et al. Gene expressions of opioid receptors and G-proteins in pineal glands. Biochem Biophys Res Commun 1999;262: 775-780.
39. ROZENFELD-GRANOT G, TOREN A, AMARIGLIO N et al. MAP kinase activation by mu opioid receptor in cord blood CD34(+)CD38(-) cells. Exp Hematol 2002;30: 473-480.